News

Asthma, a chronic condition that affects the airways in the lungs, can lead to a range of symptoms that interfere with daily life. While most people are familiar with the most common symptoms of asthma such as wheezing or whistling sounds, shortness of breath, chest tightness and frequent coughing, several others are not as widely recognized.

Like clockwork, two times a year — cold and flu season and allergy season — we get a tingle in our sinuses that can only mean one thing: The snot floodgates are about to open.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.